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Introduction
Labor and delivery can rapidly change from a normal to a potentially
high risk situation. Accordingly, careful monitoring of mother and
fetus has become the standard of care. Continuous electronic "fetal"
monitoring (EFM) of fetal heart rates and uterine contractions is used
almost universally in the United States. EFM information is sensitive
to the possibility of dangerous deficits in fetal oxygen supply.
However EFM data yields about 50 to 60% false positive "diagnoses"
of significant fetal hypoxia (1) and may not detect up to 15-20% of
true hypoxia. The most specific index of prolonged and potentially
dangerous insufficient oxygen delivery is fetal blood pH (BpH);
measured from drops of blood carefully collected from a small
incision on the fetal scalp. The combination of BpH and EFM data
reduces the incidence of false positives, while also improving
detection of true problems. These combined data can be used to
substantially reduce the Cesarean section rate for fetal distress (1-4).
It is estimated that BpH information may be clinically important in
up to 25% of patients (3,5).
However, BpH data is not commonly available because of the skills,
time, inconvenience and laboratory facilities needed to obtain
reliable measurements. Further one BpH measure is insufficient to
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determine the trend of fetal pH (5). Finally, the tools and methods
are primitive and there is some fetal risk (2). For all these reasons,
and despite its potential value, BpH has not become the standard of
practice in the United States.
The information inherent in the BpH measurement could be made
widely available if there were a convenient safe probe to
continuously monitor intrapartum fetal pH. This paper describes an
investigational fetal pH probe designed to be safe and convenient. At
this time, the goal of the device is to provide reliable fetal pH status
and trend data for use as an adjunct to EFM and BpH data for clinical
care.
Historical Perspective
The first fetal pH probe to undergo widespread clinical trials was the
Stamm tissue pH (tpH) probe, designed for monitoring the pH of the
subcutaneous fluid in the fetal scalp (6,7). Several studies
demonstrated the validity of the basic concept of Stamm: human
fetal acid-base balance can be monitored and evaluated by
continuous monitoring of the scalp tpH (8-12). Clinical utility
included a reduction in operative intervention for deliveries (9).
However the Stamm device required sterile assembly and charging
with sterile reference electrolyte a scalp incision for probe insertion
and mastery of a difficult technique for apply and fixing the probe to
the fetal scalp. The system was found to be impractical and the
technique unreliable for routine clinical use.
In order to help to make these potentially valuable fetal tpH data
generally available the authors and clinician investigators are
evaluating a system and tpH probe designed to be convenient, safe,
and reliable for continuous monitoring of fetal pH status. Fiberoptic,
electro-optic, microprocessor and analytic chemistry technologies
were integrated to produce a feasibility system designed for
evaluation of continuous clinical monitoring of the fetal pH status
during labor: The OBpH™ 1000 System. Using the experience gained
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in monitoring over 300 patients between late 1983 through mid
1985, a total system designed to be convenient and simple for
routine use by the clinician was designed and built. The latter
system, the OBpH 1500, is in evaluation at this time. This paper
describes the OBpH 1500 system and outlines clinical results from
the earlier OBpH 1000 system, which used the same tpH probe.
Because this is an unreleased FDA Class III Investigational Devise in
evaluation for regulatory purposes, International Biomedics can
make no claims regarding safety, effectiveness or utility of the
system. Further, it should be understood the device is designed as
an adjunct to EFM and fetal scalp blood sampling, not as a total
replacement for either measurement. (1987)
System Description
The OBpH 1500 System includes a fetal scalp pH ECG probe, an
applicator tool, an electro-optic Interface module, an off-line
Calibration chamber, and a fetal monitor for data display (Figures
1,2). The probe is a 22 gauge spiral ECG electrode which includes a
fiberoptic-based pH sensor (Fig. 3,4). The probe is applied to the
fetal scalp with the same general technique used for spiral ECG
electrodes. When properly placed within the scalp, the pH sensor is
within the subcutaneous fluid and the probe detects both
subcutaneous fluid (tissue) pH and fetal ECG.
The probe is supplied in a sterile pack, with the tpH sensor within pH 7.00
buffer. After insertion of the probe pack and connector into the Interface,
and insertion of the Interface into the Calibrator, the probe is
automatically warmed, stabilized, stored and calibrated within the sterile
pack. PH 7.36 Calibration is begun by depressing a sealed plunger through
the cover of the sterile probe pack. The Calibrator checks for problems,
confirms the reliability of the calibration, and the probe is ready for use
within about 15 minutes. The calibrated probe can be used with








Figure I The OBpH 1500 System
This illustrates the bedside monitoring configuration of the system. The OBpH Module
(Interface), an electro-optic and memory module which can contain the OBpH probe
set. The OBpH Interface mates with the Patient Module of the FetaScan 1500. This
assembly can be placed at the bedside, as the Patient Module accepts the EGG leg plate
cable and uterine contraction transducers and the OBpH Interface can include a
calibrated probe ready for use.
The OBpH Interface acquires and retains the probe calibration data, allowing the
patient to be disconnected from the monitor for transport by disconnecting the














(1) Open connector chamber of sterile pack.
Insert connector Into tpH Interface.
(2) .Insert sterile pack Into tpH Interface.
(3) Insert tpH Interface Into Calibrator.
Al low for stabilization, calibrate ten
minutes before needed.
(4) When calibrated, remove Interface from
calibrator, connect Interface to patient
module. Probe Is ready to use.
Preparation of the Model 1500 OBpH System
The OBpH 1500 Interface mates with either the calibrator or the monitor. It acquires
and retains the probe calibration data, allowing the patient to be disconnected from
and reconnected to any appropriate FetaScan 1500 monitor by disconnecting and
reconnecting the interface, without disconnecting the probe.
The OBpH probe is in a sterile sealed package and it can be fully calibrated in this
package without impairing sterility. Once calibrated, it can be placed at the bedside
ready for use. The semiautomatic Calibrator holds 4 probe-interface packages ready









Tissue-2 to 6 mm
Figure 3
Drawing of the tpH probe in situ in the fetal scalp, with the applicator tool attached.
The spiral forms one pole of the EGG electrode and the hub is the other. The tpH
sensor window is just below the skin surface, facing into the subcutaneous tissue in
order to measure the pH of the interstitial fluid.
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Figure 4 Principle of Operation of the Fiberoptic pH Probe
The above assembly is inserted into the solution to be measured. Protons (H+)
diffuse freely through the dialysis hollow fiber into the dye column. The
column contains a reversible pH-sensitive non-toxic dye covalently bound to a
gel matrix (to prevent escape of dye). A fiberoptic fiber guides light to the
dye, and directs reflected light to the instrument. There the green
reflectance, the red reflectance, and the current with no light (dark current)
are measured. The absorbance of green light by the dye is proportional to the
pH in the range of interest, while red absorbance is not affected by pH. The
red relectance is used as a reference signal.
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The Interface module, with probe still attached, is then moved to the
bedside. The pack is opened and the probe applied to the fetal scalp.
The interface module is then attached to the FetaScan monitor, which
automatically acquires and merges the tpH with the monitoring data
on its strip chart and the video display, and continuously checks the
validity of the optical data in order to flag problems (Fig. 5).
ILLUSTRATIVE DATA
INTRAPARTUM FETAL tpH MONITORING
Figure 5 Chart Display of Simultaneous Fetal Monitor and
OBpH Data
The fetal heart rate (FHR) demonstrates significant decelerations concordant
with uterine activity (UA). The U A channel includes a tpH scale which ranges
from pH 7.00 (bottom of record) to 7.40 (top of UA channel). The tpH is
displayed as a linear graph on the UA channel, and it is updated every 20
seconds with the average tpH for the past 20 seconds. Each minute the average
tpH is printed on the FHR channel (vertical printed statements). The FetaScan
video displays the 20 second updated tpH value.
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In-Vitro Performance of the OBpH System
In order to be useful as a trend monitor the OBpH system must
resolve changes in pH at least as well as the current technology: the
BpH. The 95% confidence interval (ci) of the BpH measurement is
reported to be 0.06 pH or greater, with a non-Gaussian distribution
(13,14). In-vitro studies of the OBpH probe demonstrate the 95% ci
is 0.03 pH (Fig. 6). The absolute accuracy is within ±0.05 pH of a
blood gas analyzer, which is also within the 95% confidence limits of
blood measurement. Published data (8,15) show the high degree of
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Figure 6 Reproducibility of pH Measurement with a Single
Fiberoptic tpH Probe
The OBpH 1500 data is compared to blood gas analyzer pH (BGpH) at eight data
points. The probe is first calibrated and then immersed in buffers of six other
pH, and it is recycled through all eight pH at least twice. The probe must
reproduce each data point within a bandwidth of ±0.03pH.
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Clinical Investigational Plan
The feasibility model 1000 OBpH system was used in eight U.S.
centers to monitor over 300 term or post-date high risk patients
where BpH was indicated. The BpH was used to document th£
reliability of the current technology, the BpH, in following trends and
to validate the reliability and the OBpH monitor in following trends
of fetal pH status and in classifying fetal pH status as normal vs. not-
normal.
The study goals:
1. Document the incidence of fetal or maternal problems caused by
the OBpH in order to compare its safety with current technology.
2. Measure the inherent reliability of the tpH data for monitoring
fetal pH status. "Inherent" means both the BpH and the OBpH
data were unflawed or untainted, according to the investigator's
report and an independent non-clinician reviewer at
International Biomedics.
3. Document the perceived added value and clinical relevance of the
OBpH monitoring data, when used as an adjunct to EFM and BpH
measurements.
Clinical Study Methods
• Subject selection criteria:
- Term or post-date patients in labor with vertex fetal
presentation, and sufficient dilation and station to properly
place the probe.
- A documented indication for fetal scalp blood sampling for pH
measurements.
- No contraindications to fetal scalp blood sampling for pH
measurements.
- Informed consent given.
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• Study Population: (Table I)
TABLE I
Study Population
QBoH 1000 OBoH 1500
Total Patients 296
Total Formal Reports 291
Average Maternal Age 25 years
Average Gestational Age 39.9 wks
Average Duration of OBpH
Monitoring 2.0 hours




































OBpH 1QQQ OBpH 1500
Neonatal Problems
Nuchal cord 9% 10%
Respiratory difficulties 3% 3%
Meconium aspiration 3% -0-
Other 7% -0-
One Minute Apgar Scores
- 3 6% -0-
4-6 18% -0-
7-10 78% 100%
Adverse Effects 3.8% -0-
• "Qualified Data Analysis" was used to measure the intrinsic
reliability of the OBpH to monitor (correlate with) fetal CpH
measurements, given no experimental flaws or "tainted data" and
given the inherent variability of the CpH data. The correlation of
replicate fetal CpH measures was determined in order to quantify the
reliability of the current technology. Next, the tpH-CpH correlation
data were calculated for those data points with replicate CpH, and
then for all qualified sets of related tpH-CpH (Table II).
• "Physiological Data Analysis" was used to measure the clinical
reliability of OBpH in trending fetal pH status, as measured by the
correlation coefficient, given no obvious problems known to the
investigator and pH values in the system operating range 7.09-7.44.
(Tables II & III).
• Reliability of classification of fetal CpH by the OBpH data. These
data included the predictive value of a normal tpH (7.20-7.44) vs. a
normal CpH (7.25+) and the accuracy of both normal and not normal
tpH to respectively predict normal & not normal CpH (efficiency of
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tpH). These data quantified the reliance the clinician can place as the
tpH reflecting the CpH status. (Tables II & III).
• Success in obtaining a reliable OBpH trend record as compared to
the success of obtaining reliable CpH measurements was measured.
Certain conditions are known to interfere with blood pH and fetal
scalp ECG reliability because free access to the scalp is blocked, and
these similarly interfere with OBpH probe fixation. The most notable
in this study was thick matted fetal hair. Meconium, scalp edema
and duration of monitoring or labor did not consistently interfere
with OBpH or BpH data.
• The potential clinical relevance of the OBpH data in patient
management in addition to the FHR and BpH data was reported on
the data forms and tallied.
TABLE II
Reliability of the OBpH 1000 Data (Feasibility Model)
Total Case Reports with





BpH/BpH: Blood pH reliability: r=0.81 r=0.71-0.90
(excluding Corometrics 220
Analyzer CpH data)
OBpH/BpH (Trending reliability): r=0.84 r=0.72-0.94
Reliability of Classification of BpH bv QBpH 1QOQ Data
Unflawed Physiological Data: n=213 pairs.
Predictive Value of Normal tpH: 100%
False normal tpH: 0%
Efficiency (correct class./total): 68%
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TABLE III
Reliability of the OBnH 1500 Data
Total Case Reports with both




BpH/BpH: Blood pH reliability: Insufficient Data
OBpH/BpH: r=0.89 r=0.79-0.93
Reliability of Classification of BpH bv OBpH 1500 Data
Unflawed Physiological Data: n=20 pairs
Predictive Value of Normal tpH: 100%
False Normal OBpH: -0-
Efficiency (correct class/total): 89%
Success in Obtaining Fetal pH Data
The clinical experience demonstrated a continuous OBpH monitoring record
could be obtained as frequently as a single valid fetal scalp blood pH data
point (80%). With the OBpH 1500, the process was perceived to be simpler
than obtaining one set of fetal scalp blood pH data point.
Clinical Relevance of the QBpH Data
The OBpH data was perceived as clinically relevant in 65% of these case
reports. The most commonly mentioned advantages were:
•Reassurance of fetal pH stability and normalcy, especially
despite other changes suggestive of possible fetal deterioration.
(Abnormal FHR, Thick Meconium) This impression was validated by the
100% predictive value of a normal tpH.
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•Avoiding extra fetal scalp blood samples.
•Detecting trends in pH before they can be resolved by the
blood pH method. (Because of the OBpH self consistency)
•Using the OBpH record as a guide to timing fetal scalp sampling
for blood pH. Usually there is no clear-cut indication as to when the pH
is changing and may need diagnostic confirmation. The OBpH trend
uniquely provides this information.
•Monitoring fetal pH status where it is impractical to obtain
timely repetitive blood pH data. This is particularly relevant during
stage II of labor, when abnormal heart rate patterns are common.
Discussion and Conclusions
The data demonstrated the OBpH system and the tpH method was
inherently capable of reliable monitoring of fetal pH status, albeit with a
different absolute value. The inherent consistency of the OBpH was
obscured by the variability of the current technology, the BpH, the
additional inter-institutional difference in BpH reliability; and possibly by
clinical factors such as thick fetal hair. Also, there is an initial learning
curve effect. At the start of the program, the correlation coefficient of tpH
to OBpH was about 0.6. The last studies revealed correlation coefficients of
0.8 to 0.95 with a few or no tainted data points. Throughout the study,
there were no false normal tpH values. When the tpH was 7.25 to 7.44, the
unflawed BpH was always in the normal range.
Most clinicians perceived the data from the OBpH system to be clinically
relevant, especially in monitoring trends of fetal pH status during
worrisome events or events where repetitive timely BpH cannot be
obtained. The investigators also immediately perceived the reliability of a
normal and stable OBpH record.
To date, the clinical results obtained from the OBpH 1500 system are
encouraging with respect to both practicality and reliability of the data.
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